Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015, 159(2):313-317 | DOI: 10.5507/bp.2013.069

Experience with the treatment of bisphosphonate-related osteonecrosis of the jaw

Zuzana Janovska, Radovan Mottl, Radovan Slezak
Department of Dentistry, Charles University in Prague, Faculty of Medicine and University Hospital Hradec Kralove, Czech Republic

Aim: This article covers the authors' experience with the treatment of bisphosphonate-related osteonecrosis of the jaw in 11 individuals.

Methods: A retrospective study of patients diagnosed and treated for bisphosphonate-related osteonecrosis of the jaw at the Department of Dentistry, University Hospital Hradec Králové during the period January 2006 to October 2012. The treatment protocol consisted of antimicrobial mouth rinses and systemic antibiotic administration according to the stage of the disease. Additional surgical debridement and sequestrectomy in combination with antimicrobial therapy was performed in two cases.

Results: Complete healing was achieved in six patients. In two cases, satisfactory healing was noted. Stage of the disease was lowered and only a small area of asymptomatic necrotic bone of up to five mm in diameter persisted. Two patients developed a stable disease without progression. In one patient, the disease progressed to the third stage with osteonecrosis involving all quadrants of both jaws.

Conclusion: From these data it was concluded that conservative approach in the treatment of bisphosphonate-related osteonecrosis of the jaw led to symptom regression but was not curative. Surgical intervention, however, bears the risk of further progression of the osteonecrosis and must be carefully planned with respect to the patient's general health status and life expectancy. The treatment of bisphosphonate-related osteonecrosis of the jaw is generally difficult. For this reason, prevention plays a predominant role in the management of the disease.

Keywords: BRONJ, bisphosphonates, osteonecrosis, jaw, treatment

Received: February 18, 2013; Accepted: September 13, 2013; Prepublished online: September 30, 2013; Published: June 28, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Janovska, Z., Mottl, R., & Slezak, R. (2015). Experience with the treatment of bisphosphonate-related osteonecrosis of the jaw. Biomedical papers, 159(2), 313-317. doi: 10.5507/bp.2013.069
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 2003;61(10):1238-9. Go to original source...
    2. Fleisch H. Bisphosphonates: mechanisms of action. Endocr Rev 2002;19(1):80-100. Go to original source... Go to PubMed...
    3. Rogers MJ, Gordon S, Benford HL, Coxon FP, Luckman SP, Monkkonen J, Frith JC. Cellular and molecular mechanism of action of bisphosphonates. Cancer 2000;88(Suppl. 12):2961-78. Go to original source... Go to PubMed...
    4. Fehm T, Beck V, Banys M, Lipp HP, Hairass M, Reinert S, Solomayer EF, Wallwiener D, Krimmel M. Bisphosphonate-inducedosteonecrosis of the jaw (ONJ): Incidence and riskfactors in patients with brest cancer and gynecologicalmalignancies. Gynecol Oncol 2009;112(3):605-9. Go to original source... Go to PubMed...
    5. Lo JC, O'Ryan FS, Gordon NP, Yang J, Hui RL, Martin D, Hutchinson M, Lathon PV, Sanchez G, Silver P, Chandra M, McCloskey CA, Staffa JA, Willy M, Selby JV, Go AS. Prevalence of osteonecrosis of the jaw in patients with oralbisphosphonateexposure. J Oral Maxillofac Surg 2010;68(2):243-53. Go to original source... Go to PubMed...
    6. Abu-Id MH, Warnke PH, Gottschalk J, Springer I, Wiltfang J, Yahya A, Russo PAJ, Kreusch T. "Bis-phossy jaws" - high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw. J Craniomaxillofac Surg 2008;36(2):95-103. Go to original source... Go to PubMed...
    7. Diel IJ, Fogelman I, Al-Nawas B, Hoffmeister B, Migliorati C, Gligorov J, Väänänen K, Pylkkänen L, Pecherstorfer M, Aapro MS. Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: Is there a diverse relationship of amino- and non-aminobisphosphonates? Crit Rev Oncol Hematol 2007;64(3):198-207. Go to original source... Go to PubMed...
    8. Manfredi M, Merigo E, Guidotti R, Meleti M, Vescovi P. Bisphosphonate-related osteonecrosis of the jaws: a case series of 25 patients affected by osteoporosis. Int J Oral Maxillofac Surg 2011;40(3):277-84. Go to original source... Go to PubMed...
    9. Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws - 2009 update. J Oral Maxillofac Surg 2009;67(Suppl 5):2-12. Go to original source... Go to PubMed...
    10. Subramanian G, Cohen HV, Quek SY. A model for the pathogenesis of bisphosphonate-associated osteonecrosis of the jaw and teriparatide's potential role in it's resolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;112(6):744-53. Go to original source... Go to PubMed...
    11. Bagan JV, Jimenez Y, Murillo J, Hernandez S, Poveda R, Sanchis JM, Diaz JM. Jaw osteonecrosis associated with bisphosphonates: multiple exposed areas and its relationship to teeth extractions. Study of 20 cases. Oral Oncol. 2006;42(3):327-9. Go to original source... Go to PubMed...
    12. Vescovi P, Campisi G, Fusco V, Mergoni G, Manfredi M, Merigo E, Solazzo L, Gabriele M, Gaeta GM, Favia G, Peluso F, Colella G. Surgery-triggered and non surgery-triggered bisphosphonate-related osteonecrosis of the jaws (BRONJ): A retrospective analysis of 567 cases in an Italian multicenter study. Oral Oncol 2011;47(3):191-4. Go to original source... Go to PubMed...
    13. Alons K, Kuijpers SC, De Jong E, Van Merkesteyn JP. Treating low- and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;107(2):1-7. Go to original source... Go to PubMed...
    14. Moretti F, Pelliccioni GA, Montebugnoli L, Marchetti C. A prospective clinical trial for assessing the efficacy of a minimally invasive protocol in patients with bisphosphonate-associated osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;112(6):777-82. Go to original source... Go to PubMed...
    15. Pavlicová A, Vavřičková L, Slezák R, Mottl R. Vlastní zkušenosti s léčbou bisfosfonáty indukovanou osteonekrózou čelistních kostí. LKS 2010;20(5):104-8.
    16. Tubiana-Hulin M, Spielmann M, Roux C, Campone M, Zelek L, Gligorov J, Samson J, Lesclous P, Laredo JD, Namer M. Physiopathology and management of osteonecrosis of the jaws related to bisphosphonate therapy for malignant bone lesions. A French expert panel analysis. Crit Rev Oncol Hematol 2009;71(1):12-21. Go to original source... Go to PubMed...
    17. Bedogni A, Saia G, Bettini G, Tronchet A, Totola A, Bedogni G, Ferronato G, Nocini PF, Blandamura S. Long-term outcomes of surgical resection of the jaws in cancer patients with bisphosphonate-related osteonecrosis. Oral Oncol 2011;47(5):420-4. Go to original source... Go to PubMed...
    18. Wilde F, Heufelder M, Winter K, Hendricks J, Frerich B, Schramm A, Hemprich A. The role of surgical therapy in the management of intravenous bisphosphonate-related osteonecrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;111(2):153-63. Go to original source... Go to PubMed...
    19. Williamson RA. Surgical management of bisphosphonate induced osteonecrosis of the jaws. Int J Oral Maxillofac Surg 2010; 39(3): 251-5. Go to original source... Go to PubMed...
    20. Pautke C, Bauer F, Otto S, Tischer T, Steiner T, Weitz J, Kreutzer K, Hohlweg-Majert B, Wolff KD, Hafner S, Mast G, Ehrenfeld M, Stürzenbaum SR, Kolk A. Fluorescence-guided bone resection in bisphosphonate-related osteonecrosis of the jaws: first clinical results of a prospective pilot study. J Oral Maxillofac Surg. 2011;69(1):84-91. Go to original source... Go to PubMed...
    21. Kos M, Kuebler JF, Luczak K, Engelke W. Bisphosphonate-related osteonecrosis of the jaws: a review of 34 cases and evaluation of risk. J Craniomaxillofac Surg 2010;38(4):255-9. Go to original source... Go to PubMed...
    22. Bauer JS, Beck N, Kiefer J, Stockmann P, Wichmann M, Eitner S. Awareness and education of patients receiving bisphosphonates. J Craniomaxillofac Surg 2012;40(3):277-82 Go to original source... Go to PubMed...
    23. Ripamonti CI, Maniezzo M, Campa T, Fagnoni E, Brunelli C, Saibene G, Bareggi C, Ascani L, Cislaghi E. Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan. Ann Oncol 2009;20(1):137-45. Go to original source... Go to PubMed...
    24. Schubert M, Klatte I, Linek W, Müller B, Döring K, Eckelt U, Hemprich A, Berger U, Hendricks J. The Saxon Bisphosphonate Register - Therapy and prevention of bisphosphonate-related osteonecrosis of the jaws. Oral Oncol 2012;48(4):349-54. Go to original source... Go to PubMed...
    25. Janovská Z. Bisphosphonate-related osteonecrosis of the jaws. A severe side effect of bisphosphonate therapy. Acta Medica (Hradec Králové) 2012;55(3):111-5. Go to original source... Go to PubMed...
    26. Patel V, McLeod NM, Rogers SN, Brennan PA. Bisphosphonate osteonecrosis of the jaw--a literature review of UK policies versus international policies on bisphosphonates, risk factors and prevention. Br J Oral Maxillofac Surg 2011;49(4):251-7. Go to original source... Go to PubMed...

    Return to the content